Background This review aimed to better understand experiences of being invited to cancer screening and associated decision-making.
Introduction
More than 50% of people in the UK born after 1960 will be diagnosed with cancer in their lifetime. 1 In order for screening to be effective in reducing cancer mortality, it is important that uptake is high. National Health Service (NHS) population screening tests for breast, cervical and colorectal cancer have uptake rates of 71%, 2 73% 3 and 52%, 4 respectively in England. Those who do not attend are more likely to be at higher risk; improving uptake is therefore a key public health strategy to reduce health inequalities in outcomes at every stage of the cancer patient pathway. 5 Ethnicity, social deprivation and gender are important determinants of cancer screening uptake. 6 Factors influencing screening uptake identified in quantitative research include practical barriers, such as difficulty making an appointment, forgetting to do so and dependency on others to carry out the activities of daily living. 7, 8 Psychosocial motivators and barriers, including embarrassment, worry, anxiety and self-efficacy have also been identified. 9, 10 Interventions to improve uptake targeting structural and system factors, such as invitation and reminder methods, and education have been demonstrated to be effective. choice about health screening found some evidence that greater informed choice does not reduce uptake but this was based on a limited number of studies. 15 A randomized controlled trial of information about overdetection in breast cancer screening found that greater knowledge about the potential harms of screening may reduce intentions to be screened. 16 Higher awareness of the risks of screening could contribute to a decline in the positive social attitudes to cancer screening which have generally been observed. 17, 18 This highlights the importance of using an exploratory approach to investigate thoughts and experiences of recipients of cancer screening invitations to better understand why a proportion of individuals do not attend when invited.
The aim of this meta-ethnography was to systematically identify and synthesize qualitative evidence which explains cancer screening attendance decisions in the UK.
Methods Eligibility criteria
Studies were eligible for inclusion if they utilized qualitative methodology and included evidence of factors influencing decisions to attend screening for cancer. We limited our search to UK studies because there are international differences in the organization and delivery of screening and a need for uptake strategies to consider health service context and cultural and societal norms. 6 At least one factor must have been described, either by a participant or the author, as having influenced the participant's prior real-life screening attendance decision.
Screening programmes eligible for inclusion were organised population screening and research trials of screening methods. Opportunistic screening, self-examination, second stage screening (e.g. a diagnostic test following an abnormal screen), genetic testing and family history counselling were all ineligible. Reports solely of the views of people other than the screening invitation recipient (e.g. healthcare practitioners) were ineligible. Research which reported screening attendance decisions exclusively in individuals with symptoms of the disease, a previous cancer diagnosis, physical or learning disabilities, or who had experienced sexual abuse were ineligible.
Several data sources were searched (see Supplementary data, Table S1 ), reference lists of included studies were searched for further relevant references and Web of Science was used to search for papers citing the included studies. Search results from each source were combined and duplicates removed. Titles and abstracts were screened for eligibility independently by B.Y. and L.B. A third researcher (R.d.N.) was available to resolve any disagreements. Full text papers were retrieved and the eligibility of each paper for inclusion was assessed by B.Y. and L.B. Papers assessed as eligible were then classified independently by both B.Y. and L.B. according to a typology of findings in qualitative research. 19 This addressed the problem that methodologies stated by qualitative study authors often do not accurately reflect those which are used. The typology outlines five categories which classify study findings as qualitative or not qualitative depending on the degree of data transformation (see Supplementary data, Table S2 ). Studies classified as 'qualitative findings' were included and others were excluded.
Study characteristics were extracted from included papers. Quotes and text from papers which met the criteria were extracted into a spreadsheet by B.Y., coded as first-or second-order constructs 20 and as primary or secondary data (Supplementary data, Fig. S1 ).
Appraisal of included papers was conducted independently by both B.Y. and L.B. using the Critical Appraisal Skills Programme (CASP) tool for qualitative research. 21 The tool has 10 questions which assist in forming a judgement of the validity and value of reports. It was not used to numerically score papers on their quality. By taking into account the CASP tool, typology of findings, conceptual richness and relevance and contribution to the review question, papers were categorized as a key paper, satisfactory paper or fatally flawed. Such an approach allows the value and importance of qualitative studies in answering a research question to be tempered by the validity of the findings. 22 This categorization was used to guide the synthesis, allowing more emphasis to be placed on key papers.
The synthesis of findings involved interpretative analysis using meta-ethnography (Supplementary data, Fig. S2 ). 23 Included papers were carefully read and the relationships between the concepts arising in the papers considered using a matrix of shared themes. Thematic coding was undertaken, firstly with data extracted from key papers and continued through all included studies. When a new theme was identified, the other papers were reviewed to check for the presence of the theme, forming a cyclical process. Studies were compared and contrasted via an interpretative reading of meaning of conceptual data. Third-order constructs 24 were developed by taking the first-and second-order constructs and analysing them thematically to form a new interpretation.
Results

Summary of included studies
Thirty-six papers reporting 34 different studies were included in a 'reciprocal synthesis' 23 ( Fig. 1) . The characteristics and relevant findings of included studies are shown in Table 1 . Twenty-one papers had cancer screening uptake as the main focus of the reports. The primary focus of other reports included wider knowledge and attitudes to cancer and prevention, [46] [47] [48] [49] [50] [51] [52] responses to information about screening, [53] [54] [55] [56] experiences of screening test results 57, 58 and risk management options which included screening. 59, 60 Cervical, breast and colorectal cancer accounted for 29 of the 34 studies. Two related to prostate cancer, two to ovarian and one to lung cancer. Five papers were categorized as key papers 32, 35, 36, 42, 53 and the rest as satisfactory.
Evidence synthesis
Three primary themes emerged from the analysis: first, screening attendance decisions were shaped by individuals' relationships with the health service. Second, fear was a dominant influence on both decisions to attend and to not attend. Third, experiences of risk were expressed throughout the data. Additionally, a range of other factors interacted with these primary themes as described below. The distribution of themes across the 36 papers is shown in the Supplementary data, Table S3 . Illustrative quotes from study participants (P) and authors (A) are provided below and further supporting data excerpts are shown in the Supplementary data, Table S4 . A diagram of third-order constructs and their relationships is shown in Fig. 2 .
Relationship with health service
Responses to screening invitations were largely explained in terms of individuals' relationship with the health service. There was a wide range of levels of trust evident in the data, ranging from those who interpreted the invitation as a command to be obeyed, to those who perceived it as an attempt at control to be resisted. Between these two extremes, individuals cited other aspects of the relationship which influenced their decision.
There was evidence that the NHS is seen as a higher power in the relationship: 'Many interviewees referred to having a smear test as a "correct" form of behaviour: as the right/correct/proper thing for women to do. Notions of deviance were associated with non-attendance.'(A) 48 Some felt obliged to comply with the 'system' in order that they are taken seriously when presenting with other health problems in the future. 41 In this sense, they viewed trust as something to be demonstrated and maintained in both directions in the relationship. In contrast, others felt privileged to Records identified through database searching (n = 17226)
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Social norms
Test is embarrassing, encouraged to participate by others who had done so be invited to screening 56 and viewed it as the offer of a valuable service at no financial cost to them. 36 Immigrant populations with limited experience of the NHS lacked trust in its services and employees, sometimes opting to be screened in their home country where a stronger relationship existed with the healthcare provider. 40 Language problems inhibited them from asking questions and forming a trusting relationship. 38 There was distrust of interpreters provided by the NHS who were described as unqualified to translate using medical terminology. 44 There were perceptions from ethnic minority groups that screening services did not (or would not) meet their cultural and religious needs. 'They just make you feel uncomfortable [for requesting a female nurse]. So that is why I don't go, if I got the test I would say no I don't want to go because of this thing.'(P) 25 Associations of cervical screening with promiscuity raised concerns about confidentiality in women who did not trust clinicians and receptionists to meet these needs. 45 Another aspect of the relationship which influenced decisions was the communication flowing from the health service to the individual containing information about screening and the potential harms and benefits. Different levels of knowledge about screening resulted from this information, but in those who did not attend there was often a deficit in knowledge and understanding about screening, which they were not motivated to overcome: 'Throughout the focus groups the women expressed a lack of awareness about the need for cervical screening, resulting in the women ignoring an invite for cervical screening.'(A) 33 'Expressions such as 'never knew anything about cancer before'; 'I never knew'; 'I didn't know what is cancer' were common.'(A) 50 There were expectations that screening should take place in a clinical setting and that patients are the passive receiver of care from the screening provider. 35 The receipt of home testing kits for colorectal cancer, for example, was interpreted as unusual and impersonal. The detachment of screening from clinical settings was linked to non-uptake: 'Self-testing at home … undermined the value and relevance of screening.'(A) 35 Invitations endorsed by general practitioners (GPs) carried additional weight and were revered, especially in those holding a biomedical view of the health service relationship in which the medical profession was seen as the sole decision-makers. 25 For women, the relationship with the health service was sometimes not perceived to be strong enough to entertain the prospect of attending screening, during which they would be required to reveal private parts of their body to a stranger. 45 There was a theme of control and surveillance experienced by women, within a discourse from the provider of the female body being a site of risk in need of medical observation, 48 or feelings their bodies were being used to fulfil quotas 45 or achieve other objectives. 
Fear
Fears about cancer screening manifested as both a motivator and barrier to screening attendance. Four key sources of fear were screening invitations, the threat of cancer in the absence of screening, the threat of abnormal test results and screening methods. The receipt of a cancer screening invitation was experienced as provoking varying levels of fear, often explaining avoidance or delay in participation. Non-attenders described being 'terrified' and 'frightened to death' by the invitation, 42 leading to a quick decision to not respond. Less extreme experiences of fear were carefully negotiated by talking to others and seeking more information about screening. An incentive to take up screening was anticipation that in doing so fear may be reduced. Fear of developing cancer in the absence of screening was a powerful motivator to attend which facilitated the overcoming of other perceived barriers to screening: 'Fear appeared to be the main driving force behind the decision to have smear tests.'(A) 48 Implications of an abnormal screening test result were a principal source of fear in the data. This was interpreted as 'fear of the unknown' and fear of an inability to cope with a diagnosis and 'the word cancer' itself. 42 Fears about screening methods were commonly cited, either from previous experience or from anecdotes heard from others. These were anticipated as leading to other negative emotions including pain, discomfort and embarrassment.
Other sources of fear were the potential social inadequacy in the performance of an unfamiliar event under professional scrutiny, 36 anticipation of having to wait for screening results, a general fear of hospitals and medical procedures 42 and stigma associated with cancer or cancer risk. 50 
Experiences of risk
Closely related to the first two themes was that of risk. Individuals were subject to external discourses of risk and also created their own 'game of chance'. 36 The official discourse on screening from the health service was one which labels individuals as 'at risk', non-attenders as at even higher risk and attenders as at lower risk. There was, however, some resistance to this discourse, influenced by themes of beliefs about the disease and current health and wellness. For example, individuals who believed that an absence of symptoms and a feeling of wellness placed them at low risk cited this as a reason for either attending or not attending screening: 'I'd almost be surprised if I did get it, I don't feel anything.'(P) 43 They felt they had either nothing to gain or nothing to lose by screening. Beliefs were expressed that risk of cancer was reduced by participation in screening. This may be a coping strategy to gain protection from the risk and uncertainty of the threat of cancer. Beliefs about cancer also influenced risk in minority ethnic groups, for example beliefs that talking about cancer or being in close proximity to someone with cancer can put one at risk. 50 This likely represents a culture in which cancer is a taboo subject and is avoided.
Discussion
Main findings of this study This meta-ethnography provides an insight into the thoughts and experiences which explained participants' screening attendance decisions. Three primary themes emerged from the synthesis.
Individuals' relationship with the health service was the most important factor, influenced by underlying dynamics of trust, power, control and authority. Some were compliant with screening requests, particularly when received from a known source. For example, invitations received from GPs were more trusted than those received from screening hubs. This is consistent with experimental research demonstrating that GP endorsement promotes higher uptake. 61 However, in a society where ever more areas of our lives are under routine surveillance, this synthesis found individuals can be sceptical of the requirement to adhere to a screening regime. Their resistance is interpreted as an attempt to maintain control over their own bodies and their right to decide when they are unwell and need medical attention. 48 A general distrust of those in power is a social dynamic that can include the NHS, which is viewed by some as an extension of the Government. 36 A further demonstration of the level of trust necessary in the relationship was the cultural and language needs which were seen as being unmet. Immigrant groups experience additional barriers due to a lack of familiarity with the NHS and limited knowledge of services. A fundamental aspect to the relationship with the screening provider is the information received and resulting knowledge and understanding. In screening, this communication typically occurs in writing and many of the nuances of communication that could contribute to a trusting relationship are lost. Home visits combined with an educational video have been shown to be particularly effective in promoting screening uptake in hard to reach groups, while written translated materials were ineffective. 62 According to our analysis, ultimately it was the sender's characteristics, rather than the content of the message itself, which were important. Interventions to modify invitation materials to address other barriers may therefore have limited potential to promote uptake beyond that which has already been achieved. 11, 12, 63 Improvements in uptake may be achieved by patient-oriented interventions targeting perceptions of the wider health service, rather than screening invitation materials or methods alone. For certain groups, there may be a benefit in including key community figures (e.g. local religious leaders) in communicating the health agenda. An extension of GP involvement in cancer screening could utilize an existing trusted relationship to promote uptake. For example, a banner on the invitation letter indicating endorsement from the patient's GP practice has been shown to increase uptake of colorectal screening. 64 Such interventions could lead to other desirable outcomes as a result of increased levels of trust in the relationship.
There are consistencies with other qualitative syntheses, which report cervical screening as an emotional experience 65 and fear as a barrier in colorectal screening. 66 Our finding of experiences of fear from a number of sources in cancer screening is consistent with patients' reported experiences of seeking help for cancer symptoms. 67, 68 The role of fear and its link with cancer worry and perceived susceptibility in cancer screening uptake has received much attention. Fear of a number of aspects of screening, including the hospital setting, pain from screening procedures, test results and their consequences, was strongly associated with non-attendance in a survey. 69 In a colorectal screening trial, desire for screening was higher in people who reported worrying about cancer, but individuals were less likely to attend if they had reported feeling uncomfortable at the thought of cancer. 70 It has been suggested that fear combined with high-efficacy messages promotes health behaviour change and fear with low-efficacy messages creates defensive responses. 71 The importance of response efficacy (the perception that a behaviour will alleviate a threat) in behaviour change has been demonstrated. 72 This relationship between fear and cancer screening attendance is complex and our findings provide an insight into the different ways fear is experienced and interpreted in this context. Specifically, the synthesis supports the theory that very high levels of fear about cancer screening, from sources including screening invitations, the perceived threat of cancer, abnormal test results or the screening methods, can promote avoidance. Some overcame their fear having been persuaded by another person to attend. Increasing familiarity and trust in relation to the health service might have a similar effect in enabling individuals to negotiate moderate levels of fear in deciding to attend screening.
The analysis showed how the experience of being identified as 'at risk' by the health service led to some resistance and the creation of alternative explanations based on a range of beliefs about the disease. Evidence shows a moderate level of perceived risk optimizes screening uptake, with high levels leading to avoidance and low levels a lack of motivation. 73 A metaanalysis of a range of behaviours suggests that this relationship between a threat and behaviour holds only when accompanied by high self-and response-efficacy. 74 Our study found individuals create their own perceptions of risk irrespective of the 'official discourse' and use screening as a coping strategy.
A better understanding of the complex determinants of uptake could lead to the identification of modifiable psychological variables as targets for intervention. Current screening invitation materials emphasize the recipient's choice in deciding whether or not to take part. To complement this, the perceived control an individual has over other aspects of the process could be promoted. Rather than screening being experienced as a mass surveillance programme in which people are systematically called and recalled by a computer, personalized aspects of screening could be enhanced and the element of individual control emphasized. The aims of ensuring that individuals have the knowledge to decide what they want to do and that they feel the communication is personalized could potentially be achieved in synergy. For example, interactive methods could be used in decision aids which address gaps in knowledge, tailored to individual levels of fear and perceived risk.
Our findings could also help in understanding why certain sociodemographic groups engage less with other health processes, as there may be common barriers generalizable beyond cancer screening. The findings could further contribute to understanding of delays in help-seeking when experiencing cancer symptoms.
What is already known on this topic
There is evidence that ethnic minorities, younger aged and economically deprived groups are less likely to attend cancer screening. Quantitative research has identified some practical and psychosocial factors influencing screening uptake but has not fully explained why a proportion of individuals do not attend. Qualitative studies have reported experiences of cancer screening uptake, focusing on specific groups and types of screening tests. Their findings have not been synthesized in a way that can be integrated with the existing hierarchy of evidence to inform future research, policy and practice.
What this study adds
A synthesis of evidence from a systematic review of qualitative studies has identified important themes which influence cancer screening uptake in the UK. A higher level interpretation of data demonstrated how an individual's relationship with the health service, their fear of cancer screening and their experiences of risk influence their response to a screening invitation. This review makes this important body of evidence more accessible to clinicians, policy-makers and researchers.
Limitations of this study
Reasons for taking part or not taking part in a cancer screening research trial may differ to those for routine NHS screening. As an example, altruistic reasons for participation were particularly evident in trials of ovarian and lung screening methods. 43, 59 However, the majority of included studies related to NHS cervical, breast and colorectal screening. The studies were published over a wide time frame and therefore the experiences of participants may not all necessarily reflect the current state of screening in the UK. Recall bias could have influenced the data because participants reported past experiences. Those who are least likely to engage in screening were probably underrepresented in the data since they might be less likely to take part in a research study on the topic.
Conclusion
This synthesis highlights important factors which underpin the uptake of cancer screening. It emphasizes the importance of the provider-patient relationship in promoting informed uptake and enriches our understanding of how fear and risk are experienced and negotiated in the screening attendance decision. Further research should use quantitative methods to explore in which groups the barriers identified are prevalent and the extent to which they are experienced. The qualitative literature could be examined further to draw out differences between screening programmes and population subgroups. Interventions could be piloted to promote a perception of personalized care, improved trust in the health service and prevent extreme levels of fear and perceived risk. As cancer screening invitations change in the future, due to the use of new screening methods and the growth in importance of concepts such as informed choice and risk stratification, there will be a continuing need to explore experiences of being invited to cancer screening.
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